JP2023550840A5 - - Google Patents
Info
- Publication number
- JP2023550840A5 JP2023550840A5 JP2023532331A JP2023532331A JP2023550840A5 JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5 JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023532331 A JP2023532331 A JP 2023532331A JP 2023550840 A5 JP2023550840 A5 JP 2023550840A5
- Authority
- JP
- Japan
- Prior art keywords
- quinazoline
- fluorophenyl
- alkyl
- methyl
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20210189.5 | 2020-11-27 | ||
| EP20210189 | 2020-11-27 | ||
| PCT/EP2021/083141 WO2022112490A1 (en) | 2020-11-27 | 2021-11-26 | Amino quinazoline derivatives as p2x3 inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023550840A JP2023550840A (ja) | 2023-12-05 |
| JP2023550840A5 true JP2023550840A5 (cg-RX-API-DMAC7.html) | 2024-11-29 |
| JP7844468B2 JP7844468B2 (ja) | 2026-04-13 |
Family
ID=73642588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532331A Active JP7844468B2 (ja) | 2020-11-27 | 2021-11-26 | P2x3阻害剤としてのアミノキナゾリン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240025880A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4251620B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7844468B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230113309A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116601149A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021388923A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3196333A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES3026309T3 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023005803A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022112490A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026517300A (ja) | 2023-05-22 | 2026-05-28 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | P2x3阻害剤を調製するための方法および中間体 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2596706T3 (es) | 2006-06-29 | 2017-01-11 | F. Hoffmann-La Roche Ag | Arilamidas con sustitución de tetrazol |
| WO2008123963A1 (en) | 2007-04-02 | 2008-10-16 | Renovis, Inc. | Pyrid-2-yl fused heterocyclic compounds, and compositions and uses thereof |
| US8076345B2 (en) | 2007-04-17 | 2011-12-13 | Evotec Ag | 2-cyanophenyl-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine compounds, compositions and uses thereof |
| WO2009110985A2 (en) | 2008-02-29 | 2009-09-11 | Renovis, Inc. | Amide compounds, compositions and uses thereof |
| US20110237578A1 (en) | 2008-09-18 | 2011-09-29 | Zhi-Liang Wei | Amide compounds, compositions and uses thereof |
| WO2016084922A1 (ja) | 2014-11-28 | 2016-06-02 | 塩野義製薬株式会社 | 1,2,4-トリアジン誘導体およびその医薬組成物 |
| WO2016088838A1 (ja) | 2014-12-04 | 2016-06-09 | 塩野義製薬株式会社 | プリン誘導体およびその医薬組成物 |
| CU24411B1 (es) | 2014-12-09 | 2019-05-03 | Bayer Ag | Compuesto derivado de benzamida sustituida con 1,3-tiazol-2-ilo útil para el tratamiento de trastornos neurogénicos |
| WO2017011729A1 (en) | 2015-07-16 | 2017-01-19 | Patara Pharma, LLC | Combination therapies for the treatment of lung diseases |
| CA2998742C (en) | 2015-09-29 | 2023-08-29 | Anthony P. FORD | Diaminopyrimidine p2x3 and p2x2/3 receptor modulators for use in the treatment of cough |
| MA56022A (fr) * | 2019-05-31 | 2022-04-06 | Chiesi Farm Spa | Dérivés d'amino quinazoline servant d'inhibiteurs de p2x3 |
-
2021
- 2021-11-26 WO PCT/EP2021/083141 patent/WO2022112490A1/en not_active Ceased
- 2021-11-26 AU AU2021388923A patent/AU2021388923A1/en active Pending
- 2021-11-26 KR KR1020237018300A patent/KR20230113309A/ko active Pending
- 2021-11-26 US US18/038,744 patent/US20240025880A1/en active Pending
- 2021-11-26 JP JP2023532331A patent/JP7844468B2/ja active Active
- 2021-11-26 CN CN202180079588.2A patent/CN116601149A/zh active Pending
- 2021-11-26 EP EP21811098.9A patent/EP4251620B1/en active Active
- 2021-11-26 ES ES21811098T patent/ES3026309T3/es active Active
- 2021-11-26 MX MX2023005803A patent/MX2023005803A/es unknown
- 2021-11-26 CA CA3196333A patent/CA3196333A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7767492B2 (ja) | Glp-1受容体アゴニスト作用を持つピラゾロピリジン誘導体を含有する医薬組成物 | |
| JP3927175B2 (ja) | N−置換ヒドロキシピリミジノンカルボキサミド系hivインテグラーゼ阻害薬 | |
| US5753666A (en) | Quinolones and their therapeutic use | |
| AU2012312305B2 (en) | Acyclic cyanoethylpyrazoles as janus kinase inhibitors | |
| CA2753434C (en) | Soluble guanylate cyclase activators | |
| JP7519221B2 (ja) | 置換ピラゾロ[1,5-a]ピリミジンおよび医療疾患の治療におけるその使用 | |
| JP7013467B2 (ja) | ウイルス感染の治療又は予防用の7位置換スルホンイミドイルプリノン化合物 | |
| JP5992615B2 (ja) | 抗癌剤であるシクロプロパンカルボキサミドで置換された芳香族化合物 | |
| CA2602738C (en) | Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof | |
| TW202246232A (zh) | Tyk2抑制劑及其用途 | |
| JP6755922B2 (ja) | 新規な化合物、それらの調製及びそれらの使用 | |
| KR101053811B1 (ko) | 6-(헤테로사이클-치환 벤질)-4-옥소퀴놀린 화합물 및 hiv 인테그라아제 억제제로서의 그의 용도 | |
| JP2021505684A (ja) | ヒストンデアセチラーゼ6阻害剤としての1,2,4−オキサジアゾール誘導体 | |
| JP4540337B2 (ja) | 新規4−アミノフロピリミジン化合物およびそれらの使用 | |
| JP2019510003A (ja) | JAK阻害剤としてのピラゾロ[1,5−a]ピラジン−4−イル誘導体 | |
| JP2006502119A (ja) | 新規2,5−二置換ピリミジン誘導体 | |
| JP2005537274A (ja) | 4−アミノ置換ピリミジン誘導体 | |
| TW200845998A (en) | Heterocyclic compounds useful in treating diseases and conditions | |
| TW200410963A (en) | Heterocyclic derivatives | |
| JP2022502444A (ja) | 3−アザビシクロ[3,1,1]ヘプタン誘導体及びこれを含む薬学的組成物 | |
| EP3860998A1 (en) | Compounds and compositions for treating conditions associated with apj receptor activity | |
| JP5411867B2 (ja) | 新規sEH阻害剤およびそれらの使用 | |
| US11744824B2 (en) | 2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds | |
| TW202504604A (zh) | 小分子前列腺素f受體拮抗劑 | |
| ES2231439T3 (es) | Derivados benzooxazol como inhibidores de tnf y de pde iv. |